Copied
 
 
2022, DKK
02.05.2023
Bruttoresultat

-6.410'

Primær drift

-16.528'

Årets resultat

-16.303'

Aktiver

39.604'

Kortfristede aktiver

13.130'

Egenkapital

24.143'

Afkastningsgrad

-42 %

Soliditetsgrad

61 %

Likviditetsgrad

137 %

Resultat
02.05.2023
Årsrapport
2022
02.05.2023
2021
20.05.2022
2020
25.05.2021
2019
15.05.2020
2017
16.05.2019
Nettoomsætning4.145.000
Bruttoresultat-6.409.657-5.756.288-5.995.1518.784.408-1.125.062
Resultat af primær drift-16.527.682-14.078.472-3.591.0004.358.150-3.592.461
Indtægter af kapitalandele (tilknyttede og associerede) 00000
Finansielle indtægter16.98932.16131.8399.417150
Finansieringsomkostninger-1.294.561-213.232-1.679.563-2.121.110-12.721
Andre finansielle omkostninger00000
Resultat før skat-17.887.516-14.259.550-13.719.1712.246.457-3.605.032
Resultat-16.303.170-12.732.465-11.786.2821.702.421-3.276.293
Forslag til udbytte00000
Aktiver
02.05.2023
Årsrapport
2022
02.05.2023
2021
20.05.2022
2020
25.05.2021
2019
15.05.2020
2017
16.05.2019
Kortfristede varebeholdninger727.90900084.222
Kortfristede tilgodehavender fra salg og tjenesteydelser 7.972.6483.365.4812.833.0891.039.2703.453.718
Likvider4.429.38911.720.02226.359.64321.725.09618.146.984
Kortfristede aktiver13.129.94615.085.50329.192.73222.764.36621.684.924
Immaterielle aktiver og goodwill00000
Finansielle anlægsaktiver494.104493.129493.007488.3576.000
Materielle aktiver25.980.32028.357.10526.654.7008.355.65019.641
Langfristede aktiver26.474.42428.850.23427.147.7078.844.00725.641
Aktiver39.604.37043.935.73756.340.43931.608.37321.710.565
Aktiver
02.05.2023
Passiver
02.05.2023
Årsrapport
2022
02.05.2023
2021
20.05.2022
2020
25.05.2021
2019
15.05.2020
2017
16.05.2019
Forslag til udbytte00000
Egenkapital24.142.74240.242.56952.570.56313.474.61820.472.188
Hensatte forpligtelser1.053.000315.000000
Langfristet gæld til banker00000
Anden langfristet gæld0079.97000
Leverandører af varer og tjenesteydelser3.010.5081.188.0682.565.611816.273602.895
Kortfristede forpligtelser9.611.7312.390.0543.689.90618.133.7551.238.377
Gældsforpligtelser14.408.6283.378.1683.769.87618.133.7551.238.377
Forpligtelser14.408.6283.378.1683.769.87618.133.7551.238.377
Passiver39.604.37043.935.73756.340.43931.608.37321.710.565
Passiver
02.05.2023
Nøgletal
02.05.2023
Årsrapport
2022
02.05.2023
2021
20.05.2022
2020
25.05.2021
2019
15.05.2020
2017
16.05.2019
Afkastningsgrad -41,7 %-32,0 %-6,4 %13,8 %-16,5 %
Dækningsgrad Na.Na.-144,6 %Na.Na.
Resultatgrad Na.Na.-284,3 %Na.Na.
Varelagerets omsætningshastighed Na.Na.Na.Na.Na.
Egenkapitals-forretning -67,5 %-31,6 %-22,4 %12,6 %-16,0 %
Payout-ratio Na.Na.Na.Na.Na.
Gældsdæknings-nøgletal -1.276,7 %-6.602,4 %-213,8 %205,5 %-28.240,4 %
Soliditestgrad 61,0 %91,6 %93,3 %42,6 %94,3 %
Likviditetsgrad 136,6 %631,2 %791,2 %125,5 %1.751,1 %
Resultat
02.05.2023
Gæld
02.05.2023
Årsrapport
02.05.2023
Nyeste:01.01.2022- 31.12.2022(offentliggjort: 02.05.2023)
Information om virksomhedens regnskabsklasse:The annual report is presented in accordance with the provisions of the Danish Financial Statements Act (Årsregnskabsloven) for medium-sized enterprises in reporting class C.
Beretning
02.05.2023
Dato for ledelsens godkendelse af årsrapporten:2023-03-16
Statement by Management on the annual report
Identifikation af den godkendte årsrapport:We have on this day presented the annual report for the financial year 01. 01. 22 - 31. 12. 22 for STENOCARE A/S.
Management's review
Beskrivelse af virksomhedens væsentligste aktiviteter:Primary activities STENOCARE A/S was founded in 2017 with the purpose of supplying medical cannabis to patients in Denmark and internationally with the vision of creating a better quality of life for patients through the use of medical cannabis as an alternative and/or a supplement to traditional medicine. The Company was first to receive the Danish Medicines Agency's permission to import, distribute as well as cultivate and produce medical cannabis. The Company is a supplier of medical cannabis oil for patients in Denmark, Sweden, UK, Australia and Norway. Stenocare has an indoor production facility for the cultivation and production of medical cannabis at the Company's premises in Randers, Denmark. Stenocare has one subsidiary, Stenocare Ireland Ltd. The Subsidiary has no financial activity, and no consolidated figures apply.